- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Lynparza combo delays progression risk in prostate
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - AZN: Full year and Q4 2021 results
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi improves survival in biliary tract cancer
AnnouncementREG - AstraZeneca PLC - Imfinzi combo shows unprecedented survival in HCC
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Enhertu granted Priority Review for breast cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Neurimmune sign deal for NI006
AnnouncementREG - AstraZeneca PLC - Transfer of rights to Eklira, Duaklir completed
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca and Ionis close eplontersen deal
AnnouncementREG - AstraZeneca PLC - Ultomiris accepted for FDA Priority Review for gMG
AnnouncementREG - AstraZeneca PLC - Tezspire approved in the US for severe asthma
AnnouncementREG - AstraZeneca PLC - Saphnelo recommended for EU approval for SLE
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Evusheld US FDA EUA
AnnouncementREG - AstraZeneca PLC - AstraZeneca, Ionis to collaborate on eplontersen
Announcement